Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Hillan Kenneth J.

SEC-identified person · CIK 1600359 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Sangamo Therapeutics, INC SGMO Director filed 2020 - 2025
Zymeworks Inc. ZYME Director filed 2022 - 2023
VG Acquisition Corp. VGAC.U Head of Therapeutics filed 2021 - 2023
Zymeworks Inc. ZYME Director filed 2019 - 2021
Achaogen, Inc. AKAO Director · See Remarks filed 2014 - 2018
Relypsa Inc RLYP Director filed 2014 - 2016

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.